PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Precision medicine navigators increase genomic testing rates for Black patients with prostate cancer

Findings suggest clinical navigators could help mitigate health inequities

2023-10-02
(Press-News.org) SAN DIEGO, October 1, 2023 — The presence of a clinical navigator to act as a liaison between people with prostate cancer and the health care system greatly increases the likelihood that patients, especially Black patients, will receive advanced testing that can help predict the severity of their disease and guide treatment, a new study suggests.

The study showed patients seen by a precision medicine navigator were substantially more likely to receive genomic testing than those not seen by the navigator. Black patients, whose genomic testing rates traditionally are much lower than white patients, experienced a six-fold increase if they were seen by a navigator. Findings will be presented today at the American Society for Radiation Oncology (ASTRO) Annual Meeting. 

“Black patients with prostate cancer in the U.S. have disparately worse clinical outcomes compared to other racial groups,” said lead study author Alexander J. Allen, MD, a radiation oncology resident physician at the University of Maryland Medical Center in Baltimore. “Our findings suggest hiring a precision medicine navigator who specializes in genetic testing can improve the rates of Black patients receiving these tests, which could potentially reduce health disparities and improve outcomes.”

Research shows Black patients are 76% more likely to be diagnosed with prostate cancer than white patients and 120% more likely to die from it. This disparity stems from many factors, including lower rates of early prostate cancer screening that result in more aggressive cancers by the time Black patients are diagnosed.

Genomic testing is used to gauge the likelihood that a cancer will metastasize, or spread beyond the prostate, within the next five to 10 years; the most common form of this test is called Decipher, which analyzes RNA markers in tumor tissue samples. Research presented at ASTRO’s 2021 Annual Meeting suggested genomic testing may be better at predicting the risk for metastases than conventional prostate cancer tests, such as the Gleason score and prostate-specific antigen (PSA) levels. Dr. Allen said oncologists use the results of all three tests to guide treatment decisions.

“Genomic testing provides additional information that can alter a patient’s treatment plan,” he said. “For example, if Gleason scores and PSA levels suggest a patient has an intermediate risk for metastases, but the genetic analysis categorizes them at high risk because of the biological makeup of the tumor, then you might intensify treatment.”

Precision medicine navigators are people whose job is focused entirely on identifying patients eligible for genomic testing and then making sure the tests are completed – a task Dr. Allen said is much more complicated than it sounds.

“Obtaining genetic tests in a clinical setting is complex and requires knowledge of the submission requirements,” he said. After working with health care providers to identify which patients are eligible, the navigator helps the patient fill out requisition forms and coordinates the submission of biopsy tissue samples to the appropriate genomic testing company.

In this study, researchers compared how frequently patients with prostate cancer in a large health care system received genetic testing from the seven months prior to the arrival of a precision medicine navigator (PMN) to the seven months following the creation of that position. Of the 693 patients studied, 44.9% (n=311) were treated prior to the arrival of the PMN and 55.1% (n=382) were treated after the PMN began work. The median age in both groups was 68 years, and racial distributions were similar (60% white, 35.1% and 34% Black, 3.2% and 3.7% Asian/Pacific Islander and 1.3% and 2.1% Latino). There were no significant differences between the two groups in disease severity, type of insurance coverage or type of facility in which they were treated.

Black patients seen by the PMN were six times more likely to receive testing than those not seen by a PMN. Following the arrival of the PMN, the proportion of Black patients referred for genomic testing rose from 19% to 58%. Genomic testing rates also rose for lower-income patients (from 20% to 64%), those on Medicare and Medicaid (from 20% to 68.5%) and people who were being treated at community hospitals (from 6% to 77%), after the introduction of the PMN.

“We thought there would be some increase but did not expect the testing rates to grow so substantially,” Dr. Allen said. He also said that genomic testing results altered treatment plans for many patients who received them. “The most common way treatments were altered based on genomic testing results was in whether or not patients with intermediate risk disease were given hormone blocking therapy,” in which hormones are suppressed to stop them from fueling cancer cell growth.

Dr. Allen said the next step for his team is to design a study that investigates whether the increased rates of genomic testing ultimately lead to better patient outcomes. “We theorize that if patients are treated differently based on this new genome-based risk stratification, outcomes will improve.”

But making sure genomic testing is available to all patients who might benefit will be key to helping lessen racial disparities in prostate cancer going forward, he said. Precision medicine navigators are not funded through traditional business models, suggesting that novel funding mechanisms may need to be initiated to decrease disparities.

“As precision medicine becomes more mainstream, it has the potential to alleviate disparities,” said Dr. Allen. “But if there are no measures taken to ensure access to these tools, we could just be maintaining or even worsening the health inequities that we have today.”

###

See this study presented:

News Briefing: Monday, October 2, 11:00 a.m. Pacific time. Details here. Register here. Scientific Presentation: Sunday, October 1, 4:55 p.m. Pacific time, San Diego Convention Center. Email press@astro.org for access to the live stream or recording. Abstract Title: A precision medicine navigator can mitigate inequities associated with utilization of genomic tests in Black men with prostate cancer (Abstract 122) Attribution to the American Society for Radiation Oncology (ASTRO) Annual Meeting is requested in all coverage. View our meeting press kit at www.astro.org/annualmeetingpress.

This study was funded by an anonymous donation to the University of Maryland Precision Radiation Oncology Initiative.

ABOUT ASTRO

The American Society for Radiation Oncology (ASTRO) is the largest radiation oncology society in the world, with nearly 10,000 members who are physicians, nurses, biologists, physicists, radiation therapists, dosimetrists and other health care professionals who specialize in treating patients with radiation therapies. Radiation therapy contributes to 40% of global cancer cures, and more than a million Americans receive radiation treatments for cancer each year. For information on radiation therapy, visit RTAnswers.org. To learn more about ASTRO, visit our website and media center and follow us on social media.

END


ELSE PRESS RELEASES FROM THIS DATE:

Play in early childhood helps build a better brain, says leading expert

2023-10-02
Dr Jacqueline Harding, director of Tomorrow’s Child and an early childhood expert at Middlesex University, argues that the young child’s brain is inherently designed to be playful and this is crucial for its development. In her new book, The Brain that Loves to Play, she challenges the traditional division between play and learning, emphasizing the essential role of play in early years education and holistic child development. With a renewed vision for the fusion of play and learning, the book aims to contribute to the ...

Faith primary schools admitting fewer children with special educational needs

2023-10-02
Faith primary schools are admitting fewer children with special educational needs and disabilities (SEND) than local authority community primaries, according to new research from the London School of Economics and Political Science (LSE). In research funded by the British Academy, Dr Tammy Campbell analysed Reception year admissions to mainstream state schools from 2010-2020 in England using the National Pupil Database census.  She concluded that many faith primary schools ‘serve as hubs of relative advantage, seeming disproportionately to serve ...

Food insecurity doubles rate of severe hypoglycaemia in adults with diabetes

2023-10-02
New research being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2-6 Oct) has found that severe hypoglycaemia is more than twice as common among adults with diabetes who struggle to afford food. Severe hypoglycaemia occurs when a person’s blood sugar levels fall to such an extent that it can cause loss of consciousness, seizures, coma and, in rare cases, death. Severe hypoglycaemia is rare in people with diabetes unless they are taking insulin or secretagogues – two commonly prescribed ...

Breastfeeding is associated with lower levels of body fat at the age of nine

2023-10-02
New research being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2-6 Oct) has linked infant formula and the early introduction of fizzy drinks with higher levels of body fat later in childhood.   Youngsters who were breastfed for at least six months or longer had a lower percentage of body fat by age nine compared to those who did not receive breast milk for six months (a group that includes children who were never breastfed or received breast milk for less than 6 months).   Children ...

Exposure to daylight rather than artificial light improves blood sugar control and nutrient use in individuals with type 2 diabetes, small Dutch study finds

2023-10-02
Exposure to natural light could help treat and prevent type 2 diabetes, new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2-6 Oct), suggests. “The misalignment of our internal circadian clock with the demands of a 24/7 society is associated with an increased incidence of metabolic diseases, including type 2 diabetes,” says Ivo Habets, of Maastricht University, Maastricht, the Netherlands, who co-led the research.  “Natural daylight is the strongest zeitgeber, or environmental cue, of the circadian ...

Shorter course of radiation therapy is safe for patients with early-stage breast cancer who have undergone mastectomy and reconstruction

2023-10-01
Boston – Researchers at Dana-Farber Brigham Cancer Center have found that a shorter course of radiation therapy after mastectomy and breast reconstruction surgery provides the same protection against breast cancer recurrence and equivalent physical side-effects but substantially reduces life disruption and financial burden for patients. The results of the multicenter randomized clinical trial – the FABREC Study (Hypofractionated versus Conventionally Fractionated Postmastectomy Radiation Therapy After Implant-Based Reconstruction) – were presented ...

Short-course radiation as effective as standard treatment for patients who opt for breast reconstruction after mastectomy

2023-10-01
SAN DIEGO, October 1, 2023 — In a first-of-its-kind study, people with breast cancer who underwent implant-based breast reconstruction immediately following a mastectomy reported that getting fewer, higher doses of radiation was just as effective as standard radiation, did not increase side effects and saved them time and money. There also was a small improvement in quality of life for women under 45 who received the shortened treatment regimen. The FABREC study is the first prospective randomized study comparing quality-of-life and clinical outcomes following accelerated versus conventional radiation therapy specifically for patients with ...

Sexual activity and vaginal dilation associated with fewer side effects after cervical cancer treatment

2023-10-01
SAN DIEGO, October 1, 2023 — People who engage in sexual activity or vaginal dilation after chemoradiation treatment for cervical cancer are at lower risk for long-term side effects, according to a new study from researchers in Austria. Findings of the EMBRACE study will be presented today at the American Society for Radiation Oncology (ASTRO) Annual Meeting.  “Curing cancer is always our first priority,” said lead study author Kathrin Kirchheiner, MSc, PhD, a clinical psychologist in the department of radiation oncology at the Medical University of Vienna. “But with a growing number of relatively young cervical cancer survivors, ...

High-dose radiation offers new treatment option for older patients with inoperable kidney tumors

2023-10-01
SAN DIEGO, October 1, 2023 — Older adults diagnosed with kidney tumors that are not suitable for surgery may benefit from targeted, high-dose radiation, a new study from Australian and Dutch researchers suggests. A multi-institutional phase II study – TransTasman Radiation Oncology Group (TROG) FASTRACK II – found 100% local control and cancer-specific survival for longer than three years among patients who were treated non-invasively for inoperable kidney cancer with stereotactic ablative body radiotherapy (SABR). Findings will be presented today at the American Society for Radiation Oncology (ASTRO) ...

Liquid biopsies can rapidly detect residual disease following cervical chemoradiation, study finds

2023-10-01
SAN DIEGO, October 1, 2023 — Two liquid biopsy tests that look for the presence of human papillomavirus (HPV) in the blood accurately identified patients with a high risk of cervical cancer recurrence after the completion of chemoradiation, a new study confirms. Findings will be presented today at the American Society for Radiation Oncology (ASTRO) Annual Meeting.  The study compared two novel tests – a digital polymerase chain reaction (dPCR) test and a sequencing test for genetic material from HPV, the main cause of cervical cancer – and found they were equally effective at identifying residual disease in the blood of patients who ...

LAST 30 PRESS RELEASES:

Nanoscale topcoat can turbocharge supported gold nanoparticle catalysts

Beyond the ink: Painting with physics

Only 9 percent of older Americans were vaccinated against RSV before the disease hit this fall and winter

Evolution-capable AI promotes green hydrogen production using more abundant chemical elements

In wake of powerful cyclone, remarkable recovery of Pacific island’s forests

PSU study sheds light on 2020 extreme weather event that brought fires and snow to western US

Rice physicist earns NSF CAREER Award to revolutionize quantum technology

Mining the treasures locked away in produced water

Minoritized groups face high anxiety when taking part in research experiments

Orcas demonstrating they no longer need to hunt in packs to take down the great white shark

Scientists discover a novel vehicle for antibiotic resistance

Large-scale study explores link between smoking and DNA changes across six racial and ethnic groups

EU funding for outstanding early-career researcher Pieter Gunnink

Associate Professor Ron Korstanje, Ph.D., of The Jackson Laboratory named Evnin Family Chair

Researchers create coating solution for safer food storage

An overgrowth of nerve cells appears to cause lingering symptoms after recurrent UTIs

New findings on the immune system

Most smokers in England wrongly believe vaping is at least as harmful as smoking

New antibodies target “dark side” of influenza virus protein

Fred Hutch announces 2024 Harold M. Weintraub Graduate Student Award recipients

New academic journal on artificial intelligence launched

UMaine researchers use GPS-tracked icebergs in novel study to improve climate models

A mental process that leads to putting off an unpleasant task

The role of history in how efficient color names evolve

AI outperforms humans in standardized tests of creative potential

Study results show 25% of pregnant people are not getting enough omega-3 fatty acids from their diet or dietary supplements

Cleveland Clinic researchers uncover how virus causes cancer, point to potential treatment

SLU professor studies link between adversity, psychiatric and cognitive decline

Warwick to benefit from £2.5 million funding into “phenomenal” metamaterials

More schooling is linked to slowed aging and increased longevity

[Press-News.org] Precision medicine navigators increase genomic testing rates for Black patients with prostate cancer
Findings suggest clinical navigators could help mitigate health inequities